{"id":919893,"date":"2025-12-15T17:14:49","date_gmt":"2025-12-15T22:14:49","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec\/"},"modified":"2025-12-15T17:14:49","modified_gmt":"2025-12-15T22:14:49","slug":"bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec\/","title":{"rendered":"BD Expands BD MAX\u2122 System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\">FRANKLIN LAKES, N.J.<\/span>, <span class=\"legendSpanClass\">Dec. 15, 2025<\/span> \/PRNewswire\/ &#8212; BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the expansion of its respiratory and sexually transmitted infection (STI) diagnostics offerings in Europe following In Vitro Diagnostic Medical Device Regulation (IVDR) certification of two VIASURE assays developed by Certest Biotec for use on the BD MAX\u2122 System. The addition of these new assays to the BD MAX\u2122 System portfolio enables clinical laboratories to detect a broad range of pathogens quickly and accurately using a fully automated molecular platform.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/2845565\/BD_Expands_BD_MAX_System_Menu.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/2845565\/BD_Expands_BD_MAX_System_Menu.jpg\" title=\"BD Expands BD MAX\u2122 System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec\" alt=\"BD Expands BD MAX\u2122 System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>The newly certified assays include:<\/p>\n<ul type=\"disc\">\n<li>\n          <b>VIASURE <i>Respiratory Virus Extended Mix<\/i> Real Time PCR Detection Kit for BD MAX\u2122 System:<\/b><br \/>\n          <br \/>Detects multiple respiratory viruses, including SARS-CoV-2, flu (A and B), RSV, parainfluenza, human coronavirus, metapneumovirus, and adenovirus, from a single nasopharyngeal swab.<\/li>\n<li>\n          <b>VIASURE <i>HSV-1, HSV-2 &amp; Treponema pallidum<\/i> Assay for BD MAX\u2122 System:<\/b><br \/>\n          <br \/>Identifies the presence of herpes simplex viruses (HSV-1 and HSV-2) and the bacteria that causes syphilis (<i>Treponema pallidum<\/i>) using anogenital and oral skin lesion swabs.<\/li>\n<\/ul>\n<p>&#8220;With these two assays, we are adding clinically relevant, targeted molecular panels to our already broad respiratory and STI menu,&#8221; said Philippe\u00a0Villiard, vice president, BD Diagnostic Solutions in Europe. &#8220;Our partnership with Certest Biotec has been instrumental in expanding the BD MAX\u2122 System menu and supports our commitment to delivering innovative diagnostic solutions that enable faster, more comprehensive detection of infectious diseases on the BD MAX\u2122 System.&#8221;<\/p>\n<p>The BD MAX\u2122 System can process up to 24 samples per run and offers a comprehensive assay menu spanning HAI, respiratory, enteric, STI and women&#8217;s health panels, as well as offering open system capabilities. Designed for clinical laboratories and hospitals, the BD MAX\u2122 System combines real-time PCR technology with automated nucleic acid extraction, amplification and detection in a single streamlined workflow. It delivers results in approximately three hours with less than one minute of hands-on time per sample, providing clinicians with timely, reliable information to support accurate treatment decisions and helping improve patient care.<\/p>\n<p>&#8220;Our partnership with BD, which began in 2017, continues to grow and we are excited to strengthen our collaboration once again. We are confident that our joint efforts will result in exceptional projects in the future,&#8221; affirmed Certest&#8217;s CEO Nelson Fernandes.<\/p>\n<p>\n        <b>About\u00a0BD<\/b>\n      <\/p>\n<p>BD is\u00a0one of the\u00a0largest global medical\u00a0technology\u00a0companies\u00a0in the\u00a0world\u00a0and is\u00a0advancing\u00a0the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians&#8217; care delivery process, enable laboratory scientists to accurately detect disease and advance researchers&#8217; capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in\u00a0virtually\u00a0every\u00a0country\u00a0and\u00a0partners\u00a0with\u00a0organizations\u00a0around\u00a0the\u00a0world to\u00a0address\u00a0some\u00a0of the\u00a0most\u00a0challenging\u00a0global\u00a0health issues.\u00a0By\u00a0working in\u00a0close\u00a0collaboration\u00a0with\u00a0customers,\u00a0BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit <u><a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4580526-1&amp;h=1217492666&amp;u=http%3A%2F%2Fwww.bd.com%2F&amp;a=bd.com\" target=\"_blank\" rel=\"nofollow\">bd.com<\/a><\/u>\u00a0or connect with us on LinkedIn at <u><a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4580526-1&amp;h=3383802862&amp;u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fbd1%2F&amp;a=www.linkedin.com%2Fcompany%2Fbd1%2F\" target=\"_blank\" rel=\"nofollow\">www.linkedin.com\/company\/bd1\/<\/a><\/u>, X (formerly Twitter)\u00a0<u><a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4580526-1&amp;h=2796458380&amp;u=https%3A%2F%2Ftwitter.com%2Fbdandco&amp;a=%40BDandCo\" target=\"_blank\" rel=\"nofollow\">@BDandCo<\/a><\/u>\u00a0or Instagram <u><a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4580526-1&amp;h=1740559076&amp;u=https%3A%2F%2Finstagram.com%2Fbecton_dickinson%3Figshid%3DOGQ5ZDc2ODk2ZA%253D%253D&amp;a=%40becton_dickinson\" target=\"_blank\" rel=\"nofollow\">@becton_dickinson<\/a><\/u><\/p>\n<p>\n        <b>About Certest<\/b>\n      <\/p>\n<p>Certest Biotec is a European company established in 2002 for the development, manufacturing and commercialization of in vitro diagnostic medical devices. Today, Certest is a global company structured around four business areas: <b>Raw Materials<\/b>\u00a0under the <b>Alaset<\/b> brand, <b>Immunodiagnostics<\/b> (Rapid Tests, Turbidimetry, and CLIA), and <b>Molecular Biology<\/b> (PCR and NGS) under the <b>VIASURE<\/b> brand as well as Pharma. Offering one of the widest portfolios in human in vitro diagnostics and pharma, the company builds its future on strong technical knowledge and deep expertise in the detection of human diseases. Certest&#8217;s next generation laboratories, state-of-the-art equipment and highly skilled professionals are the foundation for delivering reliable, high-quality solutions \u00a0to medical diagnostic professionals.<\/p>\n<div>\n<table border=\"0\" cellspacing=\"0\" cellpadding=\"1\" class=\"prnbcc\">\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\"><br \/>\n                  <b>Contacts:<\/b><br \/>\n                <\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n              \n            <\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\"><br \/>\n                  <u>Media<\/u><br \/>\n                <\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\"><br \/>\n                  <u>Investors<\/u><br \/>\n                <\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">Fallon McLoughlin<br \/>Director, Public Relations<br \/>201.258.0361\u00a0 <br \/><a href=\"mailto:Fallon.Mcloughlin@bd.com\" target=\"_blank\" class=\"prnews_a\" rel=\"nofollow\">Fallon.Mcloughlin@bd.com<\/a> \u00a0<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">Adam Reiffe\u00a0<\/span>\n              <\/p>\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">Vice President, Investor Relations<\/span>\n              <\/p>\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">201.847.6927\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span>\n              <\/p>\n<p class=\"prnml4\">\n                <span class=\"prnews_span\"><br \/>\n                  <a href=\"mailto:mailto:adam.reiffe@bd.com\" target=\"_blank\" class=\"prnews_a\" rel=\"nofollow\">Adam.Reiffe@bd.com<\/a>\u00a0<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1479210\/BD_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1479210\/BD_Logo.jpg\" title=\"BD (Becton, Dickinson and Company) Logo (PRNewsfoto\/BD (Becton, Dickinson and Company))\" alt=\"BD (Becton, Dickinson and Company) Logo (PRNewsfoto\/BD (Becton, Dickinson and Company))\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=NY47471&amp;sd=2025-12-15\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec-302642368.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec-302642368.html<\/a><\/p>\n<p>SOURCE BD (Becton, Dickinson and Company)<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY47471&amp;Transmission_Id=202512151640PR_NEWS_USPR_____NY47471&amp;DateId=20251215\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire FRANKLIN LAKES, N.J., Dec. 15, 2025 \/PRNewswire\/ &#8212; BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the expansion of its respiratory and sexually transmitted infection (STI) diagnostics offerings in Europe following In Vitro Diagnostic Medical Device Regulation (IVDR) certification of two VIASURE assays developed by Certest Biotec for use on the BD MAX\u2122 System. The addition of these new assays to the BD MAX\u2122 System portfolio enables clinical laboratories to detect a broad range of pathogens quickly and accurately using a fully automated molecular platform. The newly certified assays include: VIASURE Respiratory Virus Extended Mix Real Time PCR Detection Kit for BD MAX\u2122 System: Detects multiple respiratory viruses, including SARS-CoV-2, flu &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BD Expands BD MAX\u2122 System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-919893","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BD Expands BD MAX\u2122 System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BD Expands BD MAX\u2122 System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire FRANKLIN LAKES, N.J., Dec. 15, 2025 \/PRNewswire\/ &#8212; BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the expansion of its respiratory and sexually transmitted infection (STI) diagnostics offerings in Europe following In Vitro Diagnostic Medical Device Regulation (IVDR) certification of two VIASURE assays developed by Certest Biotec for use on the BD MAX\u2122 System. The addition of these new assays to the BD MAX\u2122 System portfolio enables clinical laboratories to detect a broad range of pathogens quickly and accurately using a fully automated molecular platform. The newly certified assays include: VIASURE Respiratory Virus Extended Mix Real Time PCR Detection Kit for BD MAX\u2122 System: Detects multiple respiratory viruses, including SARS-CoV-2, flu &hellip; Continue reading &quot;BD Expands BD MAX\u2122 System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-15T22:14:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2845565\/BD_Expands_BD_MAX_System_Menu.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BD Expands BD MAX\u2122 System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec\",\"datePublished\":\"2025-12-15T22:14:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec\\\/\"},\"wordCount\":725,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2845565\\\/BD_Expands_BD_MAX_System_Menu.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec\\\/\",\"name\":\"BD Expands BD MAX\u2122 System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2845565\\\/BD_Expands_BD_MAX_System_Menu.jpg\",\"datePublished\":\"2025-12-15T22:14:49+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2845565\\\/BD_Expands_BD_MAX_System_Menu.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2845565\\\/BD_Expands_BD_MAX_System_Menu.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BD Expands BD MAX\u2122 System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BD Expands BD MAX\u2122 System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec\/","og_locale":"en_US","og_type":"article","og_title":"BD Expands BD MAX\u2122 System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec - Market Newsdesk","og_description":"PR Newswire FRANKLIN LAKES, N.J., Dec. 15, 2025 \/PRNewswire\/ &#8212; BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the expansion of its respiratory and sexually transmitted infection (STI) diagnostics offerings in Europe following In Vitro Diagnostic Medical Device Regulation (IVDR) certification of two VIASURE assays developed by Certest Biotec for use on the BD MAX\u2122 System. The addition of these new assays to the BD MAX\u2122 System portfolio enables clinical laboratories to detect a broad range of pathogens quickly and accurately using a fully automated molecular platform. The newly certified assays include: VIASURE Respiratory Virus Extended Mix Real Time PCR Detection Kit for BD MAX\u2122 System: Detects multiple respiratory viruses, including SARS-CoV-2, flu &hellip; Continue reading \"BD Expands BD MAX\u2122 System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec\/","og_site_name":"Market Newsdesk","article_published_time":"2025-12-15T22:14:49+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2845565\/BD_Expands_BD_MAX_System_Menu.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BD Expands BD MAX\u2122 System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec","datePublished":"2025-12-15T22:14:49+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec\/"},"wordCount":725,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2845565\/BD_Expands_BD_MAX_System_Menu.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec\/","name":"BD Expands BD MAX\u2122 System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2845565\/BD_Expands_BD_MAX_System_Menu.jpg","datePublished":"2025-12-15T22:14:49+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2845565\/BD_Expands_BD_MAX_System_Menu.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2845565\/BD_Expands_BD_MAX_System_Menu.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bd-expands-bd-max-system-menu-with-new-ivdr-certified-viasure-assays-in-partnership-with-certest-biotec\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BD Expands BD MAX\u2122 System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/919893","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=919893"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/919893\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=919893"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=919893"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=919893"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}